Recurrence After Treatment of Micropapillary Thyroid Cancer
Thyroid2009Vol. 19(10), pp. 1043–1048
Citations Over TimeTop 10% of 2009 papers
Douglas S. Ross, Danielle R. Litofsky, Kenneth B. Ain, Thomas Bigos, James D. Brierley, David S. Cooper, Bryan R. Haugen, Jacqueline Jonklaas, Paul W. Ladenson, James A. Magner, Jacob Robbins, Monica C. Skarulis, David L. Steward, Harry R. Maxon, Steven I. Sherman
Abstract
Patients with micropapillary multifocal disease have a reduced risk of recurrence after a T/NTT compared with less surgery. A randomized, controlled trial is necessary and feasible to determine if radioiodine ablation of thyroid remnants is advantageous in patients with intrathyroidal micropapillary cancer.
Related Papers
- → Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update(2020)98 cited
- → [Postoperative treatment of differentiated thyroid carcinoma with radioiodine-131].(2019)1 cited
- [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].(1989)
- → Perspectives of using nuclear medicine in diagnosis and treatment of thyroid cancer. II Radioiodine therapy of recurrence and metastases of differentiated thyroid cancer.(2018)